What Your MD Doesn’t Tell You Can Harm You Our

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
180
What Your MD Doesn’t Tell You Can Harm You

Our corrupt medial system

https://www.naturalblaze.com/2017/11/md-doesn...-harm.html

By Catherine J. Frompovich

The opioid problems notwithstanding, has it ever occurred to healthcare consumers and allopathic medicine’s patients as to why you aren’t told the warnings, contraindications or adverse effects regarding the Rx-prescription MDs give you, often as many as 3 “scripts” at a time, when no studies have been done to determine if there are adverse reactions or contraindications from taking various chemical pharmaceuticals and legal drugs simultaneously?

Doctors are swift to advise patients about not taking vitamins, supplements, herbal and natural remedies—that’s a known given. However, are they as quick to tell patients about the chemicals they are prescribing, often willy-nilly-like and as guesstimates? Furthermore, how many times are there prescription adverse reactions, especially with the elderly, probably resulting due to what Big Pharma’s sales reps pitch to physicians about mainstreaming new drugs or the kick-backs docs will receive for prescribing them?

By the way, the FDA maintains a reporting system called FAERS—FDA Adverse Event Reporting System—whereby “medication error reports and product quality complaints resulting in adverse events that were submitted to FDA.” However, FAERS seems to be a ‘clandestine’ and well-guarded database since one must file a FOIA report to look at the data . Hmmm! What does that tell you?

However, there is one caution MDs are fairly astute at telling patients which relates to taking grapefruit juice with certain prescription drugs. Grapefruit has the ability to decrease a pharmaceutical drug’s breakdown for elimination due to furanocoumarins, which block the CYP3A4 enzymes. This website provides a list of common drug-grapefruit interactions that, if you are taking prescriptions, you may want to print and keep.

Rx’s ability to impact driving a vehicle

Nevertheless, there is other information which MDs and pharmacists should be warning patients about and that is prescription drugs ability to impair one’s driving a motor vehicle and driving-related risk perceptions!

An October 31, 2017 study report titled “Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers” published in the Journal of Studies on Alcohol and Drugs described findings which ought to revolutionize the protocols for which pharmaceuticals are prescribed and dispensed by MDs and pharmacists alike.

The study Results found

Receipt of warnings varied by sex, race/ethnicity, income, geographic region, and time of day. For a majority of drug categories, drivers who reported receiving warnings had significantly higher odds of perceived risk of impaired driving/crash and criminal justice involvement.
It’s in the study’s Conclusions that we find one of the problems, plus pitfalls, with MDs having to push patients through their treatment rooms every twenty minutes or less:

Most users of prescription medications reported that the drug was prescribed for their use, but not all reported receiving warnings about driving impairment. Our study provides evidence of missed opportunities for information provision on impaired driving, identifies subgroups that may warrant enhanced interventions, and provides preliminary evidence that receipt of impairment warnings is associated with increased perceptions of driving-related risk.

[CJF emphasis]
MDs should be mandated by law and the AMA to give patients comprehensive warnings

But patient warnings regarding prescription medications associated with risk perceptions – for how serious that omission is for Rx-prescribed pharmaceuticals –actually pales compared with the oversight, neglect and downright deliberate refusal to instruct parents, guardians and intended vaccinees about the adverse reactions, contraindications, precautions and warnings printed in all vaccine package inserts.

How come that recent study published in the Journal of Studies on Alcohol and Drugs neglected to include vaccines?
Aren’t vaccines pharmaceuticals made by Big Pharma? Why are vaccines always EXEMPT from disclosure and patient discussions by MDs, nurses or those who administer vaccines from telling the scientific facts about adverse reactions, contraindications, precautions and warnings printed in vaccine package inserts?

The medical profession’s standard vaccine information mantra is “they are safe and effective.” Nothing is further from the facts as reported by the CDC/FDA VAERS (Vaccine Adverse Event Reporting System) and the HHS HRSA (Health Resources and Services Administration) Data and Statistics, which documents over $3.3+ BILLION paid out in claims (pg. 9) for vaccine injuries and/or deaths.

Medicare over-prescription and ‘abuse’

Here’s an example of Medicare patients prescription drug use:

The average Medicare Part D patient filled 49 standardized 30-day prescriptions in 2010. At the high end, patients in Miami, filled an average of 63 prescriptions, compared to patients in Grand Junction, Colo., who filled 39 prescriptions per year. [1]
According to the CDC website Therapeutic Drug Use, it seems we have a serious legal drug problem in the USA, which needs to be placed at the feet of the medical profession, especially MDs who get kick-backs and financial rewards for prescribing Rxs and the pharmaceutical industries incessant media advertising for Rx drugs.

Percent of persons using at least one prescription drug in the past 30 days: 48.9% (2011-2014)

Percent of persons using three or more prescription drugs in the past 30 days: 23.1% (2011-2014)

Percent of persons using five or more prescription drugs in the past 30 days: 11.9% (2011-2014)
Five or more prescription drugs in the past 30 days! Is there any wonder most senior citizens, especially those in nursing homes or other personal-care-type facilities, are drugged up like zombies?

If allopathic medicine and its acolytes are into science-based medicine, then where are the studies documenting no biochemical and/or physiological interactions when taking five or more chemical drugs simultaneously? Is that why the FAERS data is secretive?

Children’s Rx prescriptions and vaccines

Let’s not forget the kiddies! How many are taking prescription drugs and are they really necessary?

According to the CDC’s website

Seven and one-half [7.5] percent of children aged 6–17 years used prescribed medication during the past 6 months for emotional or behavioral difficulties. [CJF emphasis]
Something definitely is ethically and physiologically wrong to produce the above stats, in my opinion.

If children literally weren’t being poisoned with neurotoxic chemicals in vaccines at 2, 4 and 6 months of age and thereafter, plus not given chemical-laced water [2] and GMO ‘phood’, but taught to eat a nutritiously balanced diet not dependent on junk and sugar edibles or fried fast food restaurant offerings, most of those meds undoubtedly would not be necessary!

You can’t poison a body into wellness. But then that would not be profitable for Big Pharma and the MDs who prescribe them. Would it?

References:

[1] https://www.rwjf.org/en/library/articles-and-...isten.html
[2] http://www.fluoridation.com/quotes.htm

Resources:

“Follow The Money”: Big Pharma Swindles Insurance, Medicare and Consumers
https://www.activistpost.com/2017/10/follow-m...umers.html

Congress Is To Blame For The Opioid Epidemic Plus All Vaccine Tragedies; Investigate Both Now
https://www.activistpost.com/2017/10/congress...e-now.html

Will Opioid Lawsuits By County Officials Against Big Pharma Set Legal Precedent To Sue Vaccine Makers?
https://www.activistpost.com/2017/09/will-opi...akers.html

Catherine J Frompovich (website) is a retired natural nutritionist who earned advanced degrees in Nutrition and Holistic Health Sciences, Certification in Orthomolecular Theory and Practice plus Paralegal Studies. Her work has been published in national and airline magazines since the early 1980s. Catherine authored numerous books on health issues along with co-authoring papers and monographs with physicians, nurses, and holistic healthcare professionals. She has been a consumer healthcare researcher 35 years and counting.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MAMMOTION's Bold Leap in Robotic Lawn Care at IFA 2026

Updated Category News Views 3

MAMMOTION Makes Waves with New Robotic Mowers Gather 'round, folks, because MAMMOTION's making some noise over at IFA 2026 in Berlin. If you've been stuck battling the wild edges of your lawn with a rusty old mower, MAMMOTION might just have the tech to save your weekends—and some grass along the way. This ain't no shiny gadget; it’s a full-on upgrade to lawn war...

Continue Reading
Holland America Evolution: Revamping Luxury at Sea

Updated Category News Views 3

Setting Sail on a Fresh Wave of Luxury It's a whole new world aboard the Oosterdam, folks. Holland America's making waves with the debut of a reimagined Ocean Bar that promises to inject a healthy dose of glamour back into cruising. Forget the stuffy maritime tales of yesteryear; this isn't just a facelift—it's a full-blown Renaissance at sea. A nod to the golden age of...

Continue Reading
Beyoncé Drops Remastered 'B'DAY'; Celebrates Legacy

Updated Category News Views 2

Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...

Continue Reading
Eosera Defies Odds with Texas-Made Ear Care Dominance

Updated Category News Views 3

Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...

Continue Reading
Aardvark Therapeutics Faces Investor Lawsuit for Fraud

Updated Category News Views 1

Investors' Trust on Shaky Grounds There it is, staring right back at investors: a securities fraud class action lawsuit against Aardvark Therapeutics. Not exactly the news a shareholder wants to digest over breakfast. If you’ve got skin in the game with Aardvark Therapeutics (NASDAQ: AARD), you might wanna keep reading. Hagens Berman Sobol Shapiro LLP, a name that's no...

Continue Reading
Hamamatsu & AIxMed to Automate Cytology Workflows

Updated Category News Views 2

Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...

Continue Reading
Aristocrat's Tiki Fire Slots Heat Up North America

Updated Category News Views 0

The Polynesian Flame Ignites: Tiki Fire Hits Online Games Just when you thought the iGaming world was catching its breath, Aristocrat Interactive throws another curveball. The buzz around their Lightning Link™ series, especially the launch of High Stakes™ in July, took the scene by storm. Now, just in time for another sizzle, they've rolled out Tiki Fire™, bringing...

Continue Reading
USSM and IonicRE Partner to Enhance US Rare Earths Supply

Updated Category News Views 1

Sometimes, it's not just about playing the game, but knowing which card to play. US Strategic Metals (USSM) and Ionic Rare Earths USA just unveiled a strategic move that’s likely to shake things up in the wild world of rare earths. As the partnership gears up to build a magnet recycling facility in Missouri, there’s chatter around creating a sustainable supply chain...

Continue Reading
Wise Group Investors Alert Ahead of Key Legal Deadline

Updated Category News Views 0

Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...

Continue Reading
Curaleaf Eyes Growth: Conference Signals Opportunities

Updated Category News Views 1

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Continue Reading

Top 5 Most Recently Viewed Articles

Rock Tech Lithium and Arcore AG Merger: A Game Changer for Lithium Supply

Updated Category News Views 241

Merger Announcement between Rock Tech Lithium and Arcore AG Rock Tech Lithium Inc. (TSXV: RCK) (OTCQX: RCKTF) announced a strategic merger with Arcore AG, aiming to establish a joint venture that would revolutionize the lithium supply chain in Europe. This collaborative effort will not just create a partnership; it intends to cover the entire value chain from mining to...

Continue Reading
Mason Michell Joins CPA on Fire as New Advisory Team Lead

Updated Category News Views 356

CPA on Fire Strengthens Team with Mason Michell's Expertise In an exciting development for CPA on Fire, Mason Michell has been appointed as the new Advisory Team Lead. This strategic move aims to enhance the company's advisory services, ensuring clients receive top-notch financial guidance. Mason Michell: A Valuable Addition Michell, a seasoned CPA, brings a wealth of...

Continue Reading
Reckitt Benckiser Investors Urged to Join Class Action Suit

Updated Category News Views 230

Reckitt Benckiser Class Action Overview Investors in Reckitt Benckiser Group PLC, listed under the ticker RBGLY, are facing a pivotal moment with a significant class action lawsuit looming. Those who purchased American Depositary Shares (ADSs) between set dates are being urged to participate in this legal process. This suit highlights crucial issues around disclosures and...

Continue Reading
Plymouth Industrial REIT Expands Cincinnati Presence with New Buy

Updated Category News Views 166

Plymouth Industrial REIT Expands Cincinnati Presence BOSTON – Plymouth Industrial REIT, Inc. (NYSE: PLYM), has successfully augmented its footprint in Cincinnati through the acquisition of a small bay industrial portfolio. The total investment for this portfolio amounted to $20.1 million, promising an initial net operating income (NOI) yield of 6.8%. The portfolio...

Continue Reading
Norton Unveils Advanced AI-Driven Fraud Protection Solutions

Updated Category News Views 245

Norton Enhances Its Cyber Safety Offerings with AI Norton has recently introduced a groundbreaking suite of AI-powered features across its Cyber Safety lineup, aimed at bolstering scam protection for its users. As the digital landscape evolves, the threat of scams has significantly increased, with cybercriminals constantly developing new tactics to deceive individuals....

Continue Reading